Chemical Compound

(19S)-6,10,19-triethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

CAS Registry Number 947687-01-6
(19S)-6,10,19-triethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione 结构式
Primary record

(19S)-6,10,19-triethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

库存
937 克
纯度
98.1 %
CAS
947687-01-6

化合物标识与属性

CAS
947687-01-6
PubChem CID
58965011
SMILES
CCC1=CC2=C(C=C1O)C(=C3CN4C(=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)C3=N2)CC
Canonical SMILES
CCc1cc2nc3c(c(CC)c2cc1O)Cn1c-3cc2c(c1=O)COC(=O)[C@]2(O)CC

名称与同义词

  • Irinotecan EP Impurity G
  • 7,11-Diethyl-10-hydroxycamptothecin
  • XIS57GM9TN
  • UNII-XIS57GM9TN
  • 947687-01-6
  • SCHEMBL5649602
  • BQAJEBSARMNUPK-DEOSSOPVSA-N
  • 7,11-diethyl-10-hydroxy camptothecin
  • AC8365
  • CS-0164094
  • 7,11-Diethyl-10-hydroxy camptothecin [USP]
  • J3.130.853D
  • (S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • B2694-468001
  • (19S)-6,10,19-triethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
  • 7,11-DIETHYL-10-HYDROXY CAMPTOTHECIN [USP IMPURITY]
  • (4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
  • (S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,8,11-triethyl-4,9-dihydroxy-, (4S)-
  • (19S)-6,10,19-triethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Irinotecan USP Impurity G
  • (4S)-4,9-Dihydroxy-4,8,11-triethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (S)-4,8,11-triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione? (Irinotecan Impurity pound(c)
  • (S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
  • (S)-4,8,11-TRIETHYL-4,9-DIHYDROXY-1H-PYRANO[3?,4?:6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14-(4H,12H)-DIONE